{"transactions":[{"id":3731774,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-13T18:56:50.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":4115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2012."}],"balance_after":0,"derivative":{"exercise_price":3.07,"expiration_date":"2018-12-31","underlying":"Common Shares","underlying_shares":4115},"source":{"system":"sec-edgar","filing":"0001171843-18-008430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/ownership.xml","form_type":"4"}},{"id":3731773,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Common Shares","published_at":"2018-12-13T18:56:50.000Z","date":"2018-12-11","kind":"tax_withholding","acquired":false,"shares":1644,"price":7,"value":11508.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Company withheld the number of shares set forth above pursuant to a net settlement permitted under the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in September 2018. No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of the lock-up agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares in U.S. dollars on December 10, 2018, converted to a Canadian dollar amount for purposes of net settlementment calculations."}],"balance_after":6550,"source":{"system":"sec-edgar","filing":"0001171843-18-008430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/ownership.xml","form_type":"4"}},{"id":3731772,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Common Shares","published_at":"2018-12-13T18:56:50.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":4115,"price":3.07,"value":12633.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":8194,"source":{"system":"sec-edgar","filing":"0001171843-18-008430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/ownership.xml","form_type":"4"}},{"id":3997567,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T21:45:12.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on  January 1, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":40000,"derivative":{"exercise_price":4.75,"expiration_date":"2028-03-11","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-18-001918","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318001918/formfour.xml","form_type":"4"}},{"id":4057131,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-14T22:55:38.000Z","date":"2018-02-12","kind":"exercise","acquired":false,"shares":26748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on January 31, 2012. The date the option became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.71,"expiration_date":"2018-03-16","underlying":"Common Shares","underlying_shares":26748},"source":{"system":"sec-edgar","filing":"0001171843-18-001149","document":"f4_cohen021318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318001149/f4_cohen021318.xml","form_type":"4"}},{"id":4057130,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Common Shares","published_at":"2018-02-14T22:55:38.000Z","date":"2018-02-12","kind":"tax_withholding","acquired":false,"shares":22669,"price":3.5,"value":79341.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on February 09, 2018, which was converted to $4.41 Canadian for purposes of net settlement calculations."}],"balance_after":4079,"source":{"system":"sec-edgar","filing":"0001171843-18-001149","document":"f4_cohen021318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318001149/f4_cohen021318.xml","form_type":"4"}},{"id":4057129,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Common Shares","published_at":"2018-02-14T22:55:38.000Z","date":"2018-02-12","kind":"exercise","acquired":true,"shares":26748,"price":3.71,"value":99235.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":26748,"source":{"system":"sec-edgar","filing":"0001171843-18-001149","document":"f4_cohen021318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318001149/f4_cohen021318.xml","form_type":"4"}},{"id":4181056,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-24T22:43:32.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on October 23, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":11000,"derivative":{"exercise_price":3.1,"expiration_date":"2027-10-22","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001171843-17-006253","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184317006253/formfour.xml","form_type":"4"}},{"id":4385777,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":161776,"kind":"person","name":"COHEN CHARLES J.","position":1,"cik":"0001619967","reported_name":"COHEN CHARLES J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Biology"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-14T20:28:23.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on  January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":20000,"derivative":{"exercise_price":8.4,"expiration_date":"2027-03-12","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001171843-17-001510","document":"f4_cohen031417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184317001510/f4_cohen031417.xml","form_type":"4"}}]}